Skip to content

Relmada Therapeutics, Inc. RLMD Effective Income Tax Rate Reconciliation, Percent

Effective Income Tax Rate Reconciliation, Percent at other companies

Century Communities logo
Century CommunitiesCCS
26.3%+1.0pp
HTF
Heartflow, Inc. Common StockHTFL
0%
Popular logo
PopularBPOP
16%-4.2pp
Evolution Metals & Technologies Corp.
 logo
Evolution Metals & Technologies Corp. EMAT
0%0.0pp
Monro, Inc. logo
Monro, Inc.MNRO
29.9%+17.5pp
Belden logo
BeldenBDC
18.7%+2.4pp

Other financials

Income statement

See full
Operating income-$19.5M-6.8%
Net income-$19.1M-8.5%
EPS (diluted)-$0.22+62.1%

Balance sheet

See full
Cash & equivalents$9.8M+750%
Total debt$104.1M-40.4%
Total equity$218.7M+875%
Total assets$235.4M+750%

Cash flow

See full
Operating cash flow-$15.1M+16.6%

Valuation

See full
Market cap$677.17M+2,907%

Returns & leverage

See full
Return on equity-48.8%-20.0pp
Debt / equity0.9×0.0×
Current ratio18.3×+13.0×

Where this comes from

Reported directly by Relmada Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:EffectiveIncomeTaxRateContinuingOperations.

The official record: Relmada Therapeutics, Inc.’s 10-K, filed March 19, 2026, on SEC EDGAR. View the filing →

Ask your AI about Relmada Therapeutics, Inc.'s effective income tax rate reconciliation, percent.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Relmada Therapeutics, Inc.'s effective income tax rate reconciliation, percent?
Relmada Therapeutics, Inc. (RLMD) reported effective income tax rate reconciliation, percent of $0 in Q4 2025.
What does effective income tax rate reconciliation, percent mean?
This is the ratio of income tax expense to pre-tax income from continuing operations, representing the actual tax burden on core business activities. It is a primary indicator of the company's tax efficiency and regulatory environment impact.